Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2008

01-04-2008 | Case Report

Efficacy of Nyoshinsan/TJ-67, a traditional herbal medicine, for menopausal symtoms following surgery and adjuvant chemotherapy for premenopausal breast cancer

Authors: Toshiaki Kogure, Katsuhiko Ito, Hiroko Sato, Tomoyuki Ito, Yuko Oku, Jun Horiguchi, Izumi Takeyoshi, Takeshi Tatsumi

Published in: International Journal of Clinical Oncology | Issue 2/2008

Login to get access
Metadata
Title
Efficacy of Nyoshinsan/TJ-67, a traditional herbal medicine, for menopausal symtoms following surgery and adjuvant chemotherapy for premenopausal breast cancer
Authors
Toshiaki Kogure
Katsuhiko Ito
Hiroko Sato
Tomoyuki Ito
Yuko Oku
Jun Horiguchi
Izumi Takeyoshi
Takeshi Tatsumi
Publication date
01-04-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0718-2

Other articles of this Issue 2/2008

International Journal of Clinical Oncology 2/2008 Go to the issue

Original Article

A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer

Review Article

Current activities and future directions of the cancer registration system in Japan

Case Report

A malignant solitary fibrous tumor in the retroperitoneum

Case Report

Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer

From the Asco-Jsco Joint Symposium

Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan

From the Asco-Jsco Joint Symposium

Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits